FRA-1 as a Regulator of EMT and Metastasis in Breast Cancer

Among FOS-related components of the dimeric AP-1 transcription factor, the oncoprotein FRA-1 (encoded by <i>FOSL1</i>) is a key regulator of invasion and metastasis. The well-established FRA-1 pro-invasive activity in breast cancer, in which <i>FOSL1</i> is overexpressed in t...

Full description

Bibliographic Details
Main Authors: Laura Casalino, Francesco Talotta, Ilenia Matino, Pasquale Verde
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/9/8307
_version_ 1797602356811005952
author Laura Casalino
Francesco Talotta
Ilenia Matino
Pasquale Verde
author_facet Laura Casalino
Francesco Talotta
Ilenia Matino
Pasquale Verde
author_sort Laura Casalino
collection DOAJ
description Among FOS-related components of the dimeric AP-1 transcription factor, the oncoprotein FRA-1 (encoded by <i>FOSL1</i>) is a key regulator of invasion and metastasis. The well-established FRA-1 pro-invasive activity in breast cancer, in which <i>FOSL1</i> is overexpressed in the TNBC (Triple Negative Breast Cancer)/basal subtypes, correlates with the FRA-1-dependent transcriptional regulation of EMT (Epithelial-to-Mesenchymal Transition). After summarizing the major findings on FRA-1 in breast cancer invasiveness, we discuss the FRA-1 mechanistic links with EMT and cancer cell stemness, mediated by transcriptional and posttranscriptional interactions between <i>FOSL1</i>/FRA-1 and EMT-regulating transcription factors, miRNAs, RNA binding proteins and cytokines, along with other target genes involved in EMT. In addition to the FRA-1/AP-1 effects on the architecture of target promoters, we discuss the diagnostic and prognostic significance of the EMT-related FRA-1 transcriptome, along with therapeutic implications. Finally, we consider several novel perspectives regarding the less explored roles of FRA-1 in the tumor microenvironment and in control of the recently characterized hybrid EMT correlated with cancer cell plasticity, stemness, and metastatic potential. We will also examine the application of emerging technologies, such as single-cell analyses, along with animal models of TNBC and tumor-derived CTCs and PDXs (Circulating Tumor Cells and Patient-Derived Xenografts) for studying the FRA-1-mediated mechanisms in in vivo systems of EMT and metastasis.
first_indexed 2024-03-11T04:15:54Z
format Article
id doaj.art-252301541f244a6da62e77333d59944c
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T04:15:54Z
publishDate 2023-05-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-252301541f244a6da62e77333d59944c2023-11-17T23:07:48ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-05-01249830710.3390/ijms24098307FRA-1 as a Regulator of EMT and Metastasis in Breast CancerLaura Casalino0Francesco Talotta1Ilenia Matino2Pasquale Verde3Institute of Genetics and Biophysics “A. Buzzati Traverso”, Consiglio Nazionale delle Ricerche (CNR), Via Pietro Castellino, 111, 80131 Naples, ItalyInstitute of Genetics and Biophysics “A. Buzzati Traverso”, Consiglio Nazionale delle Ricerche (CNR), Via Pietro Castellino, 111, 80131 Naples, ItalyInstitute of Genetics and Biophysics “A. Buzzati Traverso”, Consiglio Nazionale delle Ricerche (CNR), Via Pietro Castellino, 111, 80131 Naples, ItalyInstitute of Genetics and Biophysics “A. Buzzati Traverso”, Consiglio Nazionale delle Ricerche (CNR), Via Pietro Castellino, 111, 80131 Naples, ItalyAmong FOS-related components of the dimeric AP-1 transcription factor, the oncoprotein FRA-1 (encoded by <i>FOSL1</i>) is a key regulator of invasion and metastasis. The well-established FRA-1 pro-invasive activity in breast cancer, in which <i>FOSL1</i> is overexpressed in the TNBC (Triple Negative Breast Cancer)/basal subtypes, correlates with the FRA-1-dependent transcriptional regulation of EMT (Epithelial-to-Mesenchymal Transition). After summarizing the major findings on FRA-1 in breast cancer invasiveness, we discuss the FRA-1 mechanistic links with EMT and cancer cell stemness, mediated by transcriptional and posttranscriptional interactions between <i>FOSL1</i>/FRA-1 and EMT-regulating transcription factors, miRNAs, RNA binding proteins and cytokines, along with other target genes involved in EMT. In addition to the FRA-1/AP-1 effects on the architecture of target promoters, we discuss the diagnostic and prognostic significance of the EMT-related FRA-1 transcriptome, along with therapeutic implications. Finally, we consider several novel perspectives regarding the less explored roles of FRA-1 in the tumor microenvironment and in control of the recently characterized hybrid EMT correlated with cancer cell plasticity, stemness, and metastatic potential. We will also examine the application of emerging technologies, such as single-cell analyses, along with animal models of TNBC and tumor-derived CTCs and PDXs (Circulating Tumor Cells and Patient-Derived Xenografts) for studying the FRA-1-mediated mechanisms in in vivo systems of EMT and metastasis.https://www.mdpi.com/1422-0067/24/9/8307AP-1 transcription factorsFRA-1<i>FOSL1</i>TNBCEMT
spellingShingle Laura Casalino
Francesco Talotta
Ilenia Matino
Pasquale Verde
FRA-1 as a Regulator of EMT and Metastasis in Breast Cancer
International Journal of Molecular Sciences
AP-1 transcription factors
FRA-1
<i>FOSL1</i>
TNBC
EMT
title FRA-1 as a Regulator of EMT and Metastasis in Breast Cancer
title_full FRA-1 as a Regulator of EMT and Metastasis in Breast Cancer
title_fullStr FRA-1 as a Regulator of EMT and Metastasis in Breast Cancer
title_full_unstemmed FRA-1 as a Regulator of EMT and Metastasis in Breast Cancer
title_short FRA-1 as a Regulator of EMT and Metastasis in Breast Cancer
title_sort fra 1 as a regulator of emt and metastasis in breast cancer
topic AP-1 transcription factors
FRA-1
<i>FOSL1</i>
TNBC
EMT
url https://www.mdpi.com/1422-0067/24/9/8307
work_keys_str_mv AT lauracasalino fra1asaregulatorofemtandmetastasisinbreastcancer
AT francescotalotta fra1asaregulatorofemtandmetastasisinbreastcancer
AT ileniamatino fra1asaregulatorofemtandmetastasisinbreastcancer
AT pasqualeverde fra1asaregulatorofemtandmetastasisinbreastcancer